Description
This compound may exhibit anti-angiogenic and anticancer benefit through the potential inhibition of VEGFR2 (Flk-1), Met, RET, Axl, Ron, PDGFR, FGFR1 (Flg), and FMS-related tyrosine kinases 1, 3, and 4 (FLT1/3/4).
|
|||||||||||
Specifications | |||||||||||
|